|
 
- 积分
- 3495
- 威望
- 3495
- 包包
- 4879
|
美国冷泉港和国际干细胞协会（ISSCR）联合举办的细胞编程和重编程会议（Joint CSH Asia/ISSCR Conference on Cellular Programs & Reprogramming），于2011-10-24晚到2011-10-28中午结束，共开了3天半。来自世界各地的46个演讲者，围绕以下范围：1.Human Stem Cells; 2.Control of Pluripotency; 3.Differentiation Mechanisms; 4..Cell Interactions; 5.Molecular Control; 6.Cell Lineage; 7.Cell Therapies. 进行演讲。只采取全体大会演讲的形式，没有分会场交流。全体参会人数约430人，国内参会者应在一半以上。4 j6 J" V+ u0 P& b& V
! n' |& I3 M$ S7 j0 r9 `4 N4 I
几点参会评论：+ v1 a/ H& e4 F
1.本次会议演讲范围较广，主要是干细胞的基础演讲，大概2个演讲者提到干细胞临床治疗，因此对临床医师受益有限。" G% Z* z* W' s5 j, b. {1 I
2.许多国际著名干细胞领域权威给予精彩演讲，且绝大部分演讲内容未发表，但视乎没有让人感觉“耳目一新、眼前一亮”的报告。* ?1 m6 z# r! B! N/ F5 [( h
3.国内干细胞大牛仅裴端卿、邓宏魁参会（小牛惠立建也给talk），这样的干细胞国际盛会，又是在中国举办，国内其他干细胞大牛到了哪里？为什么不参会？我非常想见到国内权威能向国际权威提几个精彩的问题，并进行辩论，但可惜没看到，只是邓宏魁、惠立建各提了一个基本的问题。国内研究生参会较多，且提问较积极，虽然问题较基本、英文发音不准，但不怯场，值得表扬。
- x2 a+ a g- X4.国际大佬基本上天天参会，较容易见到，也愿意回答问题，如国际皮肤干细胞的权威Elaine Fuchs教授，经常提问题，也天天被学生包围，不像国内某些大佬，一演讲完就找不到人了，像是怕见人。. T# N/ Q$ u9 {
5.大家几乎一致认为会议组织的很好，住宿条件非常好，5星级宾馆，宾馆周围环境非常优美。会议伙食也非常好，已听到多人抱怨说吃胖了，回去要减肥。本人多次在国外参加ISSCR组织的年会，不得不说这是吃得最好的一次。会议结束前晚组织的具有苏州特色的文艺表演，让一些国外参会者看的眼都直了。
& A( y' T$ l$ n( K& X, F' h; C2 D# ~. _: d; O: M( N
大会演讲嘉宾有：3 z& R" y6 b6 y. t% _4 h
1.Monday, October 24% a/ }5 \* R8 Q5 g6 U# w7 }
Welcome and Overview
# J' T G' u0 WChairperson: Ronald D. McKay, PhD9 Z1 @ J" ]; n" b! G; O3 g. L
, @# k* J0 Z/ `/ r& I
Opening Keynote: Elaine Fuchs, PhD, The Rockefeller University, USA 5 u% r# Q+ W$ I( D/ g% X
$ y! F- T: G1 {' `2 s9 h
2.Tuesday, October 25 Session I: Human Stem Cells: a) ^+ Z6 _; o; S5 S
Chairperson: Hongkui Deng, PhD
" `# H+ {1 s! V* ` o, U' F2 d: E4 K
Fred Gage, PhD, Salk Institute for Biological Studies, USA
* s8 D1 P( a) u* A4 x7 rEsther Y. Son, Howard University- G0 Y. y4 z8 v9 ?7 n/ n; k
Gong Chen, Pensylvania state University,
6 I6 q1 X, {. ~- b& B' uWolf Reik, MD, PhD, The Babraham Institute, United Kingdom , I1 L4 l' l* L( L; o7 X
Linzhao Cheng, PhD, Johns Hopkins University, USA , B/ {( ~$ s+ V$ ?5 V/ e
Meng Li, Imperial College London. b& O+ o4 T' g0 F1 i
Joan Li, University of Gueensland
! F, z- @) c" b, N/ d3 c# |* HRichard A. Young, PhD, Whitehead Institute/M.I.T., USA0 a; X8 Q* V3 b
% f9 O& g+ r, \* j0 Y' o. ^9 y. H, I5 q4 x
3.Session II: Control of Pluripotency
1 b/ P- |% U+ N' Z2 `( sChairperson: Hongkui Deng, PhD
; \( d3 w( O" x3 w S
( H) s; a/ E' u9 ]6 }0 Q9 Y1 AMarius Wernig, MD, Stem Cell Institute, Stanford University, USA
* b7 J, @1 H: f2 fWenyu Zhou, University of Washington, k) J' S) G: E, O
Shuibing Chen, Weill Cornell Medical College
+ h7 x# x& M0 D8 ?Jennifer Nichols, PhD, Cambridge Stem Cell Initiative, University of Cambridge, UK
! M R8 ~7 y4 G+ I8 R3 `& lYi Zhang, PhD, University of North Carolina, USA
& H7 e* E9 n: }' `- gAlice E. Chen, Stemgene Inc., Cambage
$ l* a- B& d/ d$ UHitoshi Niwa, MD, PhD, Riken Center for Developmental Biology, Japan 5 }" v4 K6 v; ^
, ^. t, [1 `& Y( K4.Session III: Poster presentations with refreshments
6 T3 @. j( Y$ f# c) U' @
2 U* \" {( C$ g- Q5. Wednesday, October 26 Session IV: Differentiation Mechanisms
( K9 o% \# E4 e3 K7 d9 U; UChairperson: V. Narry Kim, DPhill
/ ~$ H* l o/ b" l3 a; o3 D( [9 Z3 L3 `" K1 w
Duanqing Pei, PhD, Guangzhou Institute of Biomedicine and Health, China
j% l+ s& b6 z3 tFeng Ma, CAMC, ]. J G' g+ s- w% t& q
Eric Deneault, University of Montreal,
. n7 i& ~3 y( O% N/ zHongkui Deng, PhD, Peking University, China# T' u/ b$ _7 K; J
Deepak Srivastava, MD, Gladstone Institute of Cardiovascular Disease, USA9 g# y2 ^/ f1 c" H
Lijian HUI, Shanghai,0 J# Z7 r: }, M
Fiona Watt, DPhil, Cancer Research UK Cambridge Research Institute, United Kingdom
. m7 |' o+ b; u& D7 T! v- V% V# r! A/ [
6.Session V: Cell Interactions
3 k+ g6 o# v5 S8 `7 L# _: m6 yChairperson: V. Narry Kim, DPhill
- C+ y5 U2 ^. n; W# m- B3 S
4 ~: V" M/ i, w0 h/ W$ r% S0 G8 Q& BLinheng Li, PhD, Stowers Institute for Medical Research, USA
' q# P0 l" w2 ^Feng Liu, Zoology of China
" s* Q' k& V4 u# Z1 j1 d- L9 VHiromitsu Nakauchi, MD, PhD, Institute of Medical Science, University of Tokyo, Japan
# S) ]6 ?- d2 r* j" N. o* pToshio Suda, MD, Keio University School of Medicine, Japan9 w* l8 R7 r o5 u8 q( h8 h
Guoping Fan, UCLA5 [# P' \2 b5 n* l( |
Hideyuki Okano, MD, PhD, Keio University School of Medicine, Japan ) @% U# H: ?' C8 n
( h9 v6 A+ Z2 s- a
7. Thursday, October 27
8 \ w& `9 P% |# }+ V) O4 cSession VI: Molecular Control
# _0 Y0 w, J& C0 ~' |% x! u! j4 \Chairperson: Richard A. Young, PhD
$ f% Z% O# D! h% D8 T' l$ f, z8 Y8 c+ `# w( C0 r' T4 [; [8 f
Joanna Wysocka, PhD, Stanford University, USA
* L& g T. B! H+ E! s# k- x9 ^0 |1 M5 lLin He, UC Berkeley* q3 ~6 o5 y& H( _ L; |' v
Andrew Xiao, Yale University
2 A, R7 }- g8 g f% [3 dV. Narry Kim, DPhil, Seoul National University, Korea ~% G, n" z# s7 J: \
Yukiko Gotoh, PhD, University of Tokyo, Japan: n8 W' [% t+ a5 A8 E! Y
Gang Wang, CAS, China( ~$ v3 E7 \( S7 \
Shengxi Guan, New England Biolab
5 a# L: u9 `1 U8 c( a, }Zhaoyu Lin, Nanjing University4 I+ c' r* e9 q: G% k) |1 `' p% J
Haifan Lin, PhD, Yale University School of Medicine, USA- ]6 R$ w+ l7 C8 a7 X' q. K( h- ?
& s" ] R& g5 @7 p9 p: A
8.Session VII: Cell Lineage
' y' z# R! ?, y0 D* X' D+ PChairperson: Richard A. Young, PhD0 l& |2 j6 u5 P4 Y
& f# Q' V. u$ q/ w: T4 s# G( X
Anna-Katerina Hadjantonakis, MD, Memorial Sloan-Kettering Cancer Center, USA
% z/ e+ \8 h2 k- y. ?Ling-Ling Chen, PhD, Shanghai Institute for Biological Sciences, China
& Y: Q/ W- t$ E" _( aMark Krasnow, MD, PhD, Stanford University School of Medicine, USA
. W& r* s+ Z& ^# p- R/ O, {Ricardo A. Rossello, Howard Medical School
" @: A- q1 X$ n2 `& P: d9 ZSheng Ding, Gladstone Institute, UCSF$ g/ z$ m% m0 ^# V0 S& k- x: n
; X# o6 h: _% r, X7 `9.Friday, October 28 Closing Session: Cell Therapies
0 y9 ^, e# ]/ q9 bChairperson and closing remarks: Ronald D. McKay, PhD
# q0 p( m2 M4 Z( P! u z6 c# c' d, B: R0 ^: H R
Lorenz Studer, MD, PhD, Memorial Sloan Kettering Cancer Center, USA
$ e$ O- U( p. R5 n: p6 o( @" rKevin A. D'Amour, PhD, ViaCyte, Inc., USA4 O1 Y+ H$ U; G, c3 w
Tariq Enver, The Weatherall Institute of Molecular Medicine, UK 6 U% g; ], S* d) v+ C7 A- Q" ]
4 Q$ a( V- d- q! u- G! p7 cClosing Keynote: Gordon M. Keller, PhD, McEwen Center for Regenerative Medicine Ontario Cancer Institute, Canada
, Q. n9 m4 m/ S2 I) ~7 V, i% k* C2 u! t
会场照片
5 ]6 o, [0 F2 g" R. r& U) X6 ~
( X3 }, X/ P. I* a/ D" t
0 E( G7 K @) @9 K2 l |
-
总评分: 威望 + 110
包包 + 220
查看全部评分
|
发表于 2011-10-31 20:02
发表于 2011-11-1 01:03
